These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2406004)

  • 1. Mechanisms to improve chemotherapy effectiveness.
    Young RC
    Cancer; 1990 Feb; 65(3 Suppl):815-22. PubMed ID: 2406004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Strategies for the overcoming of drug resistance].
    Saijo N
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):371-81. PubMed ID: 7880108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy cancer treatment during the past sixty years].
    Furue H
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1404-11. PubMed ID: 14584272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?
    Crown J
    Lancet; 2003 Aug; 362(9385):677-8. PubMed ID: 12957087
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug dosage intensity--a panel discussion.
    McGuire WL; Goldie J; Hryniuk W; Tormey DC
    Breast Cancer Res Treat; 1987; 9(2):87-100. PubMed ID: 3620720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dose intensity in cancer chemotherapy (including high dose chemotherapy)].
    Ariyoshi Y; Ogawa M
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2699-707. PubMed ID: 7993104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curative and palliative aspects of regional chemotherapy in combination with surgery.
    Müller H; Hilger R
    Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of curative cancer therapy.
    Frei E
    Mt Sinai J Med; 1992 Oct; 59(5):408-11. PubMed ID: 1435837
    [No Abstract]   [Full Text] [Related]  

  • 9. Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies.
    Plunkett W; Gandhi V; Huang P; Robertson LE; Yang LY; Gregoire V; Estey E; Keating MJ
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):2-12. PubMed ID: 8235690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chemotherapy dose intensity on cancer patient outcomes.
    Lyman GH
    J Natl Compr Canc Netw; 2009 Jan; 7(1):99-108. PubMed ID: 19176210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic drug resistance in brain tumors.
    Phillips PC
    Neurol Clin; 1991 May; 9(2):383-404. PubMed ID: 1682794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dense chemotherapy versus conventional chemotherapy for early breast cancer: a systematic review with meta-analysis.
    Lemos Duarte I; da Silveira Nogueira Lima JP; Passos Lima CS; Deeke Sasse A
    Breast; 2012 Jun; 21(3):343-9. PubMed ID: 22425607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of dose-dense chemotherapy for breast cancer.
    Seidman AD
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():78-83. PubMed ID: 16273358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between antitumour agents and radiation and the expression of resistance.
    Hill BT
    Cancer Treat Rev; 1991 Sep; 18(3):149-90. PubMed ID: 1821327
    [No Abstract]   [Full Text] [Related]  

  • 15. [San Antonio Breast Cancer Symposium 2003. New therapeutic prospects in the treatment of early-stage breast cancer].
    Montemurro F
    Tumori; 2004; 90(1):suppl 1-16. PubMed ID: 15143995
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose and schedule as determinants of outcomes in chemotherapy for breast cancer.
    Budman DR
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):3-9. PubMed ID: 15726532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.
    Levin L; Hryniuk WM
    J Clin Oncol; 1987 May; 5(5):756-67. PubMed ID: 3572465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer chemotherapy.
    Secchi GC
    Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Anderson CP; Bleyer WA; Cairncross JG; Cloughesy T; Eck SL; Guastadisegni P; Hall WA; Muldoon LL; Patel SJ; Peereboom D; Siegal T; Neuwelt EA
    Neuro Oncol; 2001 Jan; 3(1):46-54. PubMed ID: 11305417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.